- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04652063
Osteopathic Manipulative Medicine to Reduce Developmental Delays
Using Osteopathic Manipulative Medicine on Preterm Infants in the Neonatal Intensive Care Unit to Reduce Neuromotor Developmental Delays
Study Overview
Status
Intervention / Treatment
Detailed Description
Hypothesis: High risk preterm infants born <34 weeks of gestation who receive OMM, compared to the standard supportive care, will have improved neuromotor development scores on the TIMP.
Specific Aims and Objectives:
Primary aim: To determine the difference in TIMP scores between infants who receive OMM and those who receive only standard neonatal intensive care unit (NICU) care.
Secondary aims:
- To compare length of stay between infants who receive OMM and those who receive only standard NICU care.
- To compare growth parameters including weight, length, and head circumference, (both means and Z scores) prior to discharge between infants who receive OMM and those who receive only standard NICU care.
- To compare percentage of subjects requiring nasogastric, orogastric, or gastrostomy tube feeds at discharge between infants who receive OMM and those who receive only standard NICU care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Angela K Tyson, DO
- Phone Number: 585-275-1847
- Email: angela_tyson@urmc.rochester.edu
Study Contact Backup
- Name: Elizabeth R Carbonell, MPH
- Phone Number: 585-273-2322
- Email: elizabeth_carbonell@urmc.rochester.edu
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester
-
Rochester, New York, United States, 14642
- Golisano Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 23 0/7- 33 6/7 weeks' gestational age (GA) at birth, ≥28 0/7 weeks' GA at time of consent
- stable enough to tolerate gentle manipulation
Exclusion Criteria:
- > 33 6/7 weeks' GA at birth
- known congenital and genetic abnormalities affecting neurodevelopment
- known conditions requiring surgical intervention
- severe intracranial hemorrhage or other severe neurologic complications
- parents unable to read and understand English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: OMM
Neonates randomized to receive osteopathic manipulation
|
Osteopathic evaluation and treatment (gentle touch according to published protocols) will take about 15 - 20 minutes, and will be performed every 7 - 10 days during the infant's NICU stay once they reach at minimum of at least 28 weeks corrected gestational age and until they reach 36 weeks corrected gestational age.
|
No Intervention: Control
Neonates randomized to receive standard care only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Test of Infant Motor Performance (TIMP)
Time Frame: At approximately 36 weeks' corrected gestational age
|
Standardized, validated assessment of risk for developmental delay; expected range: 20 - 90 with higher scores indicating less risk for developmental delay
|
At approximately 36 weeks' corrected gestational age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of stay
Time Frame: At NICU discharge, assessed up to 1 year
|
Number of days in Neonatal Intensive Care Unit (NICU)
|
At NICU discharge, assessed up to 1 year
|
Growth parameters - weight
Time Frame: at 36 weeks' corrected gestational age and discharge
|
weight z-score
|
at 36 weeks' corrected gestational age and discharge
|
Growth parameters - length
Time Frame: at 36 weeks' corrected gestational age and discharge
|
length z-score
|
at 36 weeks' corrected gestational age and discharge
|
Growth parameters - head circumference
Time Frame: at 36 weeks' corrected gestational age and discharge
|
head circumference z-score
|
at 36 weeks' corrected gestational age and discharge
|
Need for nasogastric (NG), orogastric (OG), or gastrostomy tube feeds at discharge
Time Frame: at NICU discharge, assessed up to 1 year
|
Number of neonates requiring NG, OG, or gastrostomy feeds at discharge from NICU
|
at NICU discharge, assessed up to 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ronnie Guillet, MD, PhD, University of Rochester
Publications and helpful links
General Publications
- Cerritelli F, Martelli M, Renzetti C, Pizzolorusso G, Cozzolino V, Barlafante G. Introducing an osteopathic approach into neonatology ward: the NE-O model. Chiropr Man Therap. 2014 May 9;22:18. doi: 10.1186/2045-709X-22-18. eCollection 2014.
- Wang L, He JL, Zhang XH. The efficacy of massage on preterm infants: a meta-analysis. Am J Perinatol. 2013 Oct;30(9):731-8. doi: 10.1055/s-0032-1332801. Epub 2013 Jan 15.
- Cerritelli F, Pizzolorusso G, Renzetti C, Cozzolino V, D'Orazio M, Lupacchini M, Marinelli B, Accorsi A, Lucci C, Lancellotti J, Ballabio S, Castelli C, Molteni D, Besana R, Tubaldi L, Perri FP, Fusilli P, D'Incecco C, Barlafante G. A multicenter, randomized, controlled trial of osteopathic manipulative treatment on preterms. PLoS One. 2015 May 14;10(5):e0127370. doi: 10.1371/journal.pone.0127370. eCollection 2015.
- Campbell SK, Swanlund A, Smith E, Liao PJ, Zawacki L. Validity of the TIMPSI for estimating concurrent performance on the test of infant motor performance. Pediatr Phys Ther. 2008 Spring;20(1):3-10. doi: 10.1097/PEP.0b013e31815f66a6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Study00005304
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurodevelopmental Abnormality
-
Sharp HealthCareCompletedNeurodevelopmental AbnormalityCanada, United States, Poland
-
Central Hospital, Nancy, FranceCompletedLong-term Neurodevelopmental Disorders of Prematurely Born Children and Parental Experience (PREMA7)Neurodevelopmental AbnormalityFrance
-
NICHD Global Network for Women's and Children's...Thomas Jefferson University; Thrasher Research Fund; RTI InternationalCompletedNeurodevelopmental AbnormalityUnited States, Zambia, Congo, The Democratic Republic of the, India, Pakistan, Guatemala
-
Helsinki University Central HospitalUniversity of Helsinki; Tampere University; Aalto UniversityRecruitingNeurodevelopmental Disorders | Child Development | Developmental Delay | Development, Infant | Neurophysiologic Abnormality | Cognitive Developmental DelayFinland
-
University Hospital PadovaUniversity of PadovaRecruitingInfant Development | Neurodevelopmental Abnormality | Hypoglycemia NeonatalItaly
-
Sharp HealthCareUniversity of Alabama at Birmingham; University of Pittsburgh; University of... and other collaboratorsRecruitingNeurodevelopmental AbnormalityUnited States, Ireland, Canada, Germany
-
University Children's Hospital, ZurichUniversity of Lausanne Hospitals; University of Bern; University of Geneva, SwitzerlandRecruitingCongenital Heart Disease | Cardiac Disease | Neurodevelopmental Abnormality | Intensive Care Neurological DisorderSwitzerland
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedNeurodevelopmental Abnormality | Transient Hypothyroxinemia of PrematurityTurkey
-
Windward Islands Research and Education FoundationNational Institutes of Health (NIH); Stanford University; St. George's UniversityCompletedNeurocognitive Deficit | Zika Virus Infection | Development, Child | Neurodevelopmental AbnormalityGrenada
-
Thomas Jefferson UniversityJawaharlal Nehru Medical College; S. Nijalingappa Medical College; Raichur Institute...Active, not recruitingAutism Spectrum Disorder | Iron Deficiency Anemia | Neurodevelopmental AbnormalityIndia
Clinical Trials on Osteopathic Manipulative Medicine
-
Ohio UniversityAmerican Osteopathic FoundationCompletedSARS-CoV2 Infection | COVID-19 Lower Respiratory InfectionUnited States
-
New York Institute of TechnologyActive, not recruitingDistorted; Balance | Post-Concussion SymptomsUnited States
-
New York Institute of TechnologyCold Spring Harbor LaboratoryCompleted
-
Nationwide Children's HospitalCompleted
-
New York Institute of TechnologyCompletedCervical DystoniaUnited States
-
New York Institute of TechnologyRecruitingDysmenorrhea PrimaryUnited States
-
New York Institute of TechnologyRecruitingParkinson's Disease | ConstipationUnited States
-
Jayla BosticCompletedRespiratory Function ImpairedUnited States
-
Northwell HealthUniversity of Pittsburgh Medical CenterCompletedConcussion Injury of Cerebrum | Cranial Osteopathic Medicine
-
West Virginia School of Osteopathic MedicineUniversity of New England; American Academy of Osteopathy; Osteopathic Research...Completed